Stomedis, UAB - financials and debts

Company age: 18 y. 4 mo.

Update

Stomedis - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 264,465 15,408 151,057 538,210 747,566 232,962 265,735 268,364
Profit before tax - - - - 8,240 - - -
Net profit -6,922 -10,440 -887 -1,482 7,004 -8,051 -11,753 -15,998
Equity 67,999 57,559 56,672 55,190 62,194 54,983 54,550 6,199
Liabilities 22,455 14,203 12,804 2,480 2,034 30,798 69,061 108
Non-current assets 12,367 9,287 6,207 3,127 1,202 782 15,412 0
Current assets 78,087 62,475 63,269 54,543 63,026 84,999 107,780 6,307
Total assets 90,454 71,762 69,476 57,670 64,228 85,781 123,192 6,307
Taxes paid
STI taxes - - - - - 262 - 6,517
Financial indicators
Revenue change y/y +27.8% -94.2% +880.4% +256.3% +38.9% -68.8% +14.1% +1.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -7.7% -14.5% -1.3% -2.6% 10.9% -9.4% -9.5% -253.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -10.2% -18.1% -1.6% -2.7% 11.3% -14.6% -21.5% -258.1%
Profit margin Net profit margin. Shows the overall profitability of the company. -2.6% -67.8% -0.6% -0.3% 0.9% -3.5% -4.4% -6.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 1.1% - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.2 0.2 0.0 0.0 0.6 1.3 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 264,465 15,408 151,057 538,210 747,566 232,962 265,735 268,364

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Stomedis - Social security debts

From To Debt, €
2025-10-16 2025-10-19 219.34
2024-06-18 2024-07-14 1.12
2024-05-16 2024-06-10 1.12
2024-04-23 2024-05-09 0.59
2024-04-16 2024-04-22 0.53
2024-03-18 2024-03-26 0.36
2024-02-19 2024-03-12 0.36
2024-01-23 2024-02-13 0.36
2024-01-16 2024-01-22 0.32
2023-12-18 2024-01-10 0.32
2023-11-16 2023-12-06 0.32
2023-10-25 2023-11-07 0.32
2023-10-17 2023-10-24 0.27
2023-09-18 2023-10-11 0.27
2023-08-17 2023-09-11 0.27
2023-07-28 2023-08-10 0.27
2023-07-26 2023-07-27 0.23
2023-07-24 2023-07-25 0.27
2023-07-18 2023-07-23 0.23
2023-06-16 2023-07-12 0.23
2023-05-16 2023-06-05 0.23
2023-05-02 2023-05-07 0.23
2023-04-26 2023-04-28 0.23
2023-04-18 2023-04-25 0.17
2023-03-16 2023-04-11 0.17
2023-02-17 2023-03-13 0.17
2023-02-06 2023-02-12 0.18
2023-01-24 2023-02-03 0.18
2022-12-16 2023-01-23 0.14
2022-11-21 2022-12-08 0.14
2022-11-17 2022-11-18 0.14
2022-10-28 2022-11-06 0.12
2022-10-18 2022-10-27 0.07
2022-09-16 2022-10-12 0.07
2022-08-23 2022-09-13 0.07
2022-07-25 2022-08-08 0.07
2022-07-18 2022-07-24 0.03
2022-06-16 2022-07-12 0.03
2022-05-17 2022-06-12 0.03

Stomedis - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Stomedis, UAB (code 301733738) is a Private Limited Liability Company engaged in the wholesale of wood, construction materials and sanitary equipment. In 2025, the company generated revenue of €268.4K, up 1.0% year on year and 15.2% over two years. However, profitability remained negative, with net loss widening to €16.0K and the profit margin declining to -6.0%. This continues a three-year pattern of losses, following net losses of €8.1K in 2023 and €11.8K in 2024. The balance sheet in 2025 was very small, with total assets of €6.3K, equity of €6.2K and liabilities of €108. Equity still represented 98.3% of assets, while debt to equity was low at 0.02, but returns on equity and assets were heavily negative because of the very limited capital base. Asset turnover was 42.55x, and revenue per employee was €268.4K. Overall, the company maintained sales growth, but losses increased and the balance sheet contracted sharply in 2025.